封面
市場調查報告書
商品編碼
1705958

全球杜普伊特倫攣縮症市場:按疾病類型、按類型和治療方法、按最終用戶、按地區

Global Dupuytrens Disease Market, By Disease Type, By Type and Treatment, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年全球杜普伊特倫攣縮症市場規模為 49.8 億美元,2032 年將達到 69.1 億美元,2025 年至 2032 年的複合年成長率為 4.8%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 49.8億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 4.80% 2032年價值預測 69.1億美元
數字。 2025 年杜普伊特倫攣縮症的全球市場佔有率(按地區分類)
全球杜普伊特倫攣縮症市場-IMG1

杜普伊特倫攣縮症是一種影響掌筋膜(皮膚下的一層纖維組織,覆蓋手掌和手指的肌腱、神經、血管和骨骼)的疾病。對於患有杜普伊特倫攣縮症的人來說,筋膜會隨著時間的推移而增厚和收縮(縮短)。在此過程中,筋膜可以拉動手指,將其推向手掌內側。結果,手指很難甚至不可能完全伸直,這種情況稱為杜普伊特倫攣縮症。隨著杜普伊特倫攣縮症的惡化,它會損害手部功能,使某些人的日常生活變得困難。在這些情況下,可以採用非手術和手術治療方法來減緩病情的進展(惡化)並改善受影響手指的運動。杜普伊特倫攣縮症的病因尚不清楚。這種疾病往往具有家族遺傳性。男性比女性更常見。杜普伊特倫攣縮症多年來逐漸惡化。這種病症始於手掌上出現一個硬塊。這個腫塊可能會疼痛,也可能不會。隨著時間的推移,腫塊會變成皮膚下的硬繩並延伸到手指。琴弦緊緊地纏繞著手指,並將它們拉向手掌,有時拉得很猛烈。

市場動態:

預計杜普伊特倫攣縮症盛行率的不斷上升將在預測期內推動全球杜普伊特倫攣縮症市場的成長。例如,根據公共關係和贏得媒體軟體公司和服務供應商Cision US Inc. 2022 年 10 月發布的數據,估計北美每年有 1,400 萬人患有杜普伊特倫攣縮症。

本研究的主要特點

  • 本報告對全球杜普伊特倫攣縮症市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和復合年成長率。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數,概述了全球杜普伊特倫攣縮症市場的主要企業。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球杜普伊特倫攣縮症市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球杜普伊特倫攣縮症市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 杜普伊特倫攣縮症盛行率不斷上升
    • 限制因素
  • 治療費用高
    • 機會
  • 新興經濟體
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章。全球杜普伊特倫攣縮症市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球杜普伊特倫攣縮症市場(依疾病類型)

  • I型
  • II型
  • III型

第6章 全球杜普伊特倫攣縮症市場(依類型),2020-2032

  • 診斷
  • 身體檢查
  • X光
  • 治療
  • 外科手術
  • 放射治療
  • 針腱膜切開術
  • 類固醇注射
  • 酵素注射
  • 職能治療
  • 其他

7. 2020 年至 2032 年全球杜普伊特倫攣縮症市場(依最終使用者分類)

  • 醫院
  • 診所
  • 學術研究所
  • 其他

8. 2020 年至 2032 年全球杜普伊特倫攣縮症市場(按地區)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第9章競爭格局

  • Endo International Plc
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • GSK Plc.
  • AstraZeneca
  • Hikma Pharmaceuticals Plc
  • LEO Pharma A/S
  • Fresenius Kabi AG
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6530

Global Dupuytrens Disease Market is estimated to be valued at USD 4.98 Bn in 2025 and is expected to reach USD 6.91 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.98 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.80% 2032 Value Projection: USD 6.91 Bn
Figure. Global Dupuytrens Disease Market Share (%), By Region 2025
Global Dupuytrens Disease Market - IMG1

Dupuytren's disease is a condition that affects the palmar fascia - the fibrous layer of tissue that lies underneath the skin and above the tendons, nerves, blood vessels, and bones in the palm and fingers. In patients with Dupuytren's disease, the fascia thickens and contracts (shortens) over time. The fascia may pull on the fingers during this process, causing them to be forced inward, toward the palm. This may make it difficult or impossible to fully straighten the fingers, resulting in what is known as a Dupuytren's contracture. In some people, a worsening Dupuytren's contracture can interfere with hand function, making it difficult to perform daily activities. When this occurs, there are non-surgical and surgical treatment options available to help slow the progression (worsening) of the disease and improve motion in the affected fingers. The cause of Dupuytren contracture is unknown. The condition tends to run in families. It is more common in men than in women. Dupuytren contracture gets worse slowly, over years. The condition begins with a firm lump in the palm of the hand. This lump can be painful or painless. Over time, the lump can extend into a hard cord under the skin and up into the finger. This cord tightens and pulls the finger toward the palm, sometimes severely.

Market Dynamics:

The increasing prevalence of Dupuytren's disease is expected to drive the growth of the global Dupuytren's disease market over the forecast period. For instance, according to data published in October 2022 by Cision US Inc., a public relations and earned media software company and services provider, an estimated 14 million people are affected by Dupuytren's disease every year in North America.

Key features of the study:

  • This report provides an in-depth analysis of the global Dupuytren's disease market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Dupuytren's disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Endo International Plc, Bristol-Meyers Squibb Company, Spear Pharmaceuticals, GSK Plc., AstraZeneca, Hikma Pharmaceuticals Plc, LEO Pharma A/S, Fresenius Kabi AG, Bayer AG, Novartis AG, Pfizer Inc., Nantong Jinghua Pharmaceutical Co., Ltd., and Actiza Pharmaceutical Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Dupuytren's disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dupuytren's disease market

Detailed Segmentation:

  • Global Dupuytren's Disease Market Segmentation, By Disease Type:
    • Type I
    • Type II
    • Type III
  • Global Dupuytren's Disease Market Segmentation, By Type:
    • Diagnosis
    • Physical Examination
    • X-ray
    • Treatment
    • Surgery
    • Radiation Therapy
    • Needle Aponeurotomy
    • Steroid Shot
    • Enzyme Injection
    • Occupational Therapy
    • Others
  • Global Dupuytren's Disease Market Segmentation, By End User:
    • Hospitals
    • Clinics
    • Academic & Research Institute
    • Others
  • Global Dupuytren's Disease Market Segmentation, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Endo International Plc
    • Bristol-Meyers Squibb Company
    • Spear Pharmaceuticals
    • GSK Plc.
    • AstraZeneca
    • Hikma Pharmaceuticals Plc
    • LEO Pharma A/S
    • Fresenius Kabi AG
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Actiza Pharmaceutical Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Dupuytren's Disease , By Disease Type
    • Market Dupuytren's Disease , By Type
    • Market Dupuytren's Disease , By End User
    • Market Dupuytren's Disease , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of Dupuytren's disease
    • Restraints
  • High cost of treatment
    • Opportunities
  • Emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Dupuytren's Disease Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Dupuytren's Disease Market, By Disease Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Type I
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Type II
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Type III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Dupuytren's Disease Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Physical Examination
  • X-ray
  • Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Surgery
  • Radiation Therapy
  • Needle Aponeurotomy
  • Steroid Shot
  • Enzyme Injection
  • Occupational Therapy
  • Others

7. Global Dupuytren's Disease Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Academic & Research Institute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Dupuytren's Disease Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country/Region, Y-o-Y Growth and By Country/Region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Endo International Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • GSK Plc.
  • AstraZeneca
  • Hikma Pharmaceuticals Plc
  • LEO Pharma A/S
  • Fresenius Kabi AG
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Analyst Views

10. Section

  • Research Methodology
  • About us